glp 1 agonist risks Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons | Dermatology and Therapy Do The Benefits of GLP-1
Description
F.RasmussenS.RossingP.IdornT

They work by slowing digestion, reducing appetite, and promoting feelings of fullness

Exenatide, released in 2005 as Byetta, is the oldest GLP analog

Weight loss varies but can be substantial
Keywords: pediatric obesity, GLP-1 receptor agonists, semaglutide, adolescent weight management, pharmacotherapy, long-term safety, health equity, obesity treatment Introduction The global pediatric obesity epidemic represents one of the most pressing public health challenges of the 21st century

November 12, 2025
